Posted on

Preliminary Evidence Of CBD

Our results provide preliminary evidence that CBD may affect the altered neuroendocrine as well as the psychological responses to acute stress in daily life in CHR (clinical high risk)  patients.

Therefore, in contrast to atypical antipsychotics, which have been shown to reduce elevated diurnal cortisol levels, but not correct the blunted cortisol response observed in psychosis, CBD may potentially attenuate abnormalities in some of the main components of the acute stress response in the CHR state, future research using larger samples would be required to confirm this suggestion.

These results are in line with previous research, which suggests that CBD may have anxiolytic and antipsychotic effects.